Prediction of esophagogastric varices associated with oxaliplatin administration.
Yosuke SattaRyuta ShigefukuTsunamasa WatanabeTakuro MizukamiTakashi TsudaTatsuya SuzukiTakuya EhiraNobuhiro HattoriHirofumi KiyokawaKazunari NakaharaHiroki IkedaKotaro MatsunagaHideaki TakahashiNobuyuki MatsumotoChiaki OkuseMichihiro SuzukiYu SunakawaHiroshi YasudaFumio ItohPublished in: JGH open : an open access journal of gastroenterology and hepatology (2021)
EGV formation could be predicted by the assessment of platelet counts and spleen size. If progressive splenomegaly and thrombocytopenia are observed not only during but also after completion of the oxaliplatin-containing chemotherapy, EGVs should be confirmed by endoscopy for avoiding subsequent rupture.